MicroRNA circolanti come biomarcatori per il diabete mellito di tipo 2: avanzamenti e prospettive future

Boecker M, Lai AG (2020) Could personalised risk prediction for type 2 diabetes using polygenic risk scores direct prevention, enhance diagnostics, or improve treatment? Wellcome Open Res 5:206 Udler MS, Kim J, von Grotthuss M et al. (2018) Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis. PLoS Med 15:e1002654 Ahlqvist E, Storm P, Käräjämäki A et al. (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 6:361–369 Ahlqvist E, Tuomi T, Groop L (2019) Clusters provide a better holistic view of type 2 diabetes than simple clinical features. Lancet Diabetes Endocrinol 7:668–669 Dennis JM, Shields BM, Henley WE et al. (2019) Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol 7:442–451 Khoshnejat M, Kavousi K, Banaei-Moghaddam AM, Moosavi-Movahedi AA (2020) Unraveling the molecular heterogeneity in type 2 diabetes: a potential subtype discovery followed by metabolic modeling. BMC Med Genom 13:119 Wesolowska-Andersen A, Brorsson CA, Bizzotto R et al (2022) Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: an IMI DIRECT study. Cell Reports Medicine 100477 Formichi C, Fignani D, Nigi L et al. (2021) Circulating microRNAs signature for predicting response to GLP1-RA therapy in type 2 diabetic patients: a pilot study. Int J Mol Sci 22(17):9454 Zampetaki A, Kiechl S, Drozdov I et al. (2010) Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107:810–817 Zhang T, Lv C, Li L et al. (2013) Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals. BioMed Res Int 2013:761617 Liu Y, Gao G, Yang C et al. (2014) The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci 15:10567–10577 Zhang T, Li L, Shang Q et al. (2015) Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals. Biochem Biophys Res Commun 463:60–63 Jiménez-Lucena R, Rangel-Zúñiga OA, Alcalá-Díaz JF et al. (2018) Circulating miRNAs as predictive biomarkers of type 2 diabetes mellitus development in coronary heart disease patients from the CORDIOPREV study. Mol Ther Nucleic Acids 12:146–157 Olivieri F, Spazzafumo L, Bonafè M et al. (2015) MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications. Oncotarget 6:35372–35382 Witkowski M, Weithauser A, Tabaraie T et al. (2016) Micro-RNA-126 reduces the blood thrombogenicity in diabetes mellitus via targeting of tissue factor. Arterioscler Thromb Vasc Biol 36:1263–1271 Amr KS, Abdelmawgoud H, Ali ZY et al. (2018) Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease. Br J Biomed Sci 75:82–87 Catanzaro G, Besharat ZM, Chiacchiarini M et al. (2018) Circulating micrornas in elderly type 2 diabetic patients. Int J Endocrinol 2018:6872635 Seyhan AA, Nunez Lopez YO, Xie H et al. (2016) Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. Sci Rep 6:31479 Ghorbani S, Mahdavi R, Alipoor B et al. (2018) Decreased serum microRNA-21 level is associated with obesity in healthy and type 2 diabetic subjects. Arch Physiol Biochem 124:300–305 Ghai V, Kim T-K, Etheridge A et al. (2019) Extracellular vesicle encapsulated MicroRNAs in patients with type 2 diabetes are affected by metformin treatment. J Clin Med 8(5):617 Sangalli E, Tagliabue E, Sala LL et al. (2020) Circulating MicroRNA-15a associates with retinal damage in patients with early stage type 2 diabetes. Front Endocrinol (Lausanne) 11:254 Wang X, Sundquist J, Zöller B et al. (2014) Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2. PLoS ONE 9:e86792 Grieco GE, Sebastiani G, Fignani D et al. (2021) Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples. STAR Protocols 2:100606